Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy
Primary result · T2D diagnoses, total screened populationResult — go to the resultOdds of detection 1.8 CI 1.0–3.0Authors' conclusion
In community pharmacy, the most effective method to uncover undiagnosed T2DM was a stepwise approach; initial risk assessment; and if appropriate an HbA1C POC test and referral.
Study context
- Population
- People screened for undiagnosed T2D in community pharmacies, Australia; 339 pharmacies339 pharmacies
- Participants
- 14,093 people
- Comparison
- Three pharmacy-based T2D screening methods: AUSDRISK alone vs AUSDRISK + HbA1c point-of-care test vs AUSDRISK + capillary blood glucose test
- Primary endpoint
- Rate of T2D diagnoses (confirmed by a GP, pathology laboratory or national diabetes register) in the total screened population
Methodological detailsnational, nationally representative sample of Australian pharmacies
- National
- Nationally representative sample of Australian pharmacies
Primary result
T2D diagnoses, total screened population
Odds of detection
1.8
CI 1.0–3.0
By group
Group A
< 0.8%
Group B
1.5%
Group C
< 0.6%
As reported in the abstract
Further findings
Met group-specific GP referral criteria
- Met group-specific GP referral criteria — Total meeting referral criteria
- 3059
Original publication
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy. Diabetes Res Clin Pract. Published 3 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →